Citation 17972

XUE,SB: LI,DD: LI,SW: YU,B: XU,P: CHENG,RX: XIAO,JJ:. (1984). A STUDY OF THE EFFECT OF ZHENGGUANGMYCIN ON THE CELL CYCLE OF CHO CELL LINE AND TUMORS WITH FLOW CYTOMETRY (FCM).. 19(7)

Citation Details

Title	A STUDY OF THE EFFECT OF ZHENGGUANGMYCIN ON THE CELL CYCLE OF CHO CELL LINE AND TUMORS WITH FLOW CYTOMETRY (FCM).
Authors	XUE,SB: LI,DD: LI,SW: YU,B: XU,P: CHENG,RX: XIAO,JJ:
Year	1984
Volume	19
Issue	7

Summary

Year: 1984

Journal: Unknown

Organisms and Their Experiments (6)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-2	ACTIVE
2	CELL CYCLE CYTOTOXICITY(G2 PHASE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-2	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-2	ACTIVE
4	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-2	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-4	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-4	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-5	ACTIVE
2	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-5	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-6	ACTIVE
2	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-6	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN B-2	ACTIVE
2	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN B-2	ACTIVE
3	CELL CYCLE CYTOTOXICITY(G2 PHASE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN B-2	ACTIVE
4	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN B-2	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-5033	ACTIVE
2	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLEOMYCIN A-5033	ACTIVE

Show SPARQL Queries (1)